Dec 29 () - Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according to the Danish ​drugmaker and Chinese drug suppliers. Novo did not give details on the new prices, ‌but media outlet Yicai reported earlier that list prices for the two highest dosages of Wegovy were cut by ‌48% to 987 yuan ($141) and 1,284 yuan per month respectively in some Chinese provinces.

Bears, stars, Battlestar Galactica

Parkinson's disease affects more than 1.1 million people in the U.S.